Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Osteosarcoma × Docetaxel × Clear all

Phase

Status

Sponsor Class

OTHER 5 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Prostatic Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Lung Neoplasms 11 Head and Neck Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Ovarian Neoplasms 5 Adenocarcinoma of Lung 5 Inflammatory Breast Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Esophageal Neoplasms 3 Breast Neoplasms, Male 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Recurrent Squamous Cell Lung Carcinoma 2 Carcinoma 2 Anatomic Stage I Breast Cancer AJCC v8 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1 Sarcoma 1

Interventions

Ifosfamide 5 Doxorubicin 4 Methotrexate 3 Etoposide 3 Cisplatin 3 Specimen Handling 2 Sorafenib 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 sargramostim 1 pepinemab 1 peginterferon alfa-2b 1 mifamurtide 1 merphos 1 lorukafusp alfa 1 irinotecan sucrosofate 1 imetelstat 1 etoposide phosphate 1 Zoledronic Acid 1 X-Rays 1 Thrombopoietin 1 Thoracotomy 1 Thoracostomy 1 Thoracoscopy 1 Reverse Transcriptase Polymerase Chain Reaction 1 Razoxane 1 Radiosurgery 1 QL1206 1 Polymerase Chain Reaction 1 Platinum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02718482 2019-05-13

OsteoREC2015

Italian Sarcoma Group

Phase 2 Terminated

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡